{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:49:39Z","timestamp":1791236979267,"version":"4.1.0"},"reference-count":41,"publisher":"PAGEPress Publications","license":[{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Monaldi Arch Chest Dis"],"abstract":"<jats:p>Interstitial lung diseases (ILDs) are an intriguing group of pulmonary disorders, which still require the study of epidemiological, genetic, pathophysiological, clinical, and radiological parameters. Pulmonary hypertension (PH) is an underreported complication in interstitial lung diseases which is associated with worse outcome. In our study, we have reported the spectrum of ILDs and estimated the prevalence of pulmonary hypertension among these subjects at a tertiary care centre. A cross-sectional study was performed in which demographical, clinical, radiological, and histological data of subjects with ILD, attending the department of Respiratory Medicine in the University was collected from 1st September 2018 to 31st August 2019. Serological tests were done wherever indicated. Standard criteria along with multidisciplinary opinion were needed to arrive at the final diagnosis. All subjects were screened for pulmonary hypertension via 2-D echocardiography. Mean pulmonary artery pressure \u226520 mmHg was used to define PH. In the defined period, 239 subjects were enrolled (58% females, n=141; mean age 52.38\u00b113.40 years). A tissue diagnosis was obtained in 34% cases.\u00a0 The most common ILD was hypersensitivity pneumonitis (32.2%), followed by autoimmune-ILD (31.4%), idiopathic pulmonary fibrosis (IPF) (15.9%) and sarcoidosis (12.6%), non-IPF idiopathic interstitial pneumonitis (2.1%) and rest 21 (5.9%) subjects were diagnosed as other types of ILD.\u00a0 Pulmonary hypertension was seen in 46.0% of subjects.<\/jats:p>","DOI":"10.4081\/monaldi.2021.2027","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T07:48:06Z","timestamp":1638863286000},"source":"Crossref","is-referenced-by-count":7,"title":["Spectrum of interstitial lung diseases and their association with pulmonary hypertension"],"prefix":"10.4081","author":[{"given":"Richa","family":"Tyagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7520-5404","authenticated-orcid":false,"given":"Surya","family":"Kant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev Kumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram Awadh Singh","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay Kumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshan Kumar","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Wakhlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anit","family":"Parihar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2360-7580","authenticated-orcid":false,"given":"Akshyaya","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riddhi","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2549","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"key":"12427","unstructured":"Selman M. Hypersensitivity pneumonitis. In: Interstitial lung disease, 5th ed. Schwarz M, and King TE Jr, editors. Shelton, CT: People\u2019s Medical Publishing House-USA; 2011. pp. 597-625."},{"key":"12428","doi-asserted-by":"crossref","unstructured":"Raghu G, Collard HR, Egan JJ, et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence- based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788.","DOI":"10.1164\/rccm.2009-040GL"},{"key":"12429","doi-asserted-by":"crossref","unstructured":"American Thoracic Society, European Respiratory Society. American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277.","DOI":"10.1164\/ajrccm.165.2.ats01"},{"key":"12430","doi-asserted-by":"crossref","unstructured":"King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011;378:1949.","DOI":"10.1016\/S0140-6736(11)60052-4"},{"key":"12431","doi-asserted-by":"crossref","unstructured":"Travis WD, Hunninghake G, King TE Jr, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 2008;177:1338.","DOI":"10.1164\/rccm.200611-1685OC"},{"key":"12432","doi-asserted-by":"crossref","unstructured":"Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008;63:v1-58.","DOI":"10.1136\/thx.2008.101691"},{"key":"12433","doi-asserted-by":"crossref","unstructured":"Cottin V, Hirani NA, Hotchkin DL, et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev 2018;27:180076.","DOI":"10.1183\/16000617.0076-2018"},{"key":"12434","doi-asserted-by":"crossref","unstructured":"Singh S, Sharma BB, Bairwa M, et al. Management of interstitial lung diseases: A consensus statement of the Indian Chest Society (ICS) and National College of Chest Physician (NCCP). Lung India 2020;37:359-78.","DOI":"10.4103\/lungindia.lungindia_275_20"},{"key":"12435","doi-asserted-by":"crossref","unstructured":"Behr J, Ryu J. H. Pulmonary hypertension in interstitial lung disease. Eur Respir J 2008;31:1357-67.","DOI":"10.1183\/09031936.00171307"},{"key":"12436","doi-asserted-by":"crossref","unstructured":"Maimon N, Salz L, Shershevsky Y, et al. Sarcoidosis-associated pulmonary hypertension in subjects with near-normal lung function. Int J Tuberc Lung Dis 2013;17:406-11.","DOI":"10.5588\/ijtld.12.0428"},{"key":"12437","doi-asserted-by":"crossref","unstructured":"Oliveira RK, Pereira CA, Ramos RP, et al. A haemodynamic study of pulmonary hypertension in chronic hypersensitivity pneumonitis. Eur Respir J 2014;44:415-24.","DOI":"10.1183\/09031936.00010414"},{"key":"12438","doi-asserted-by":"crossref","unstructured":"Koschel DS, Cardoso C, Wiedemann B, et al. Pulmonary hypertension in chronic hypersensitivity pneumonitis. Lung 2012;190:295-302.","DOI":"10.1007\/s00408-011-9361-9"},{"key":"12439","doi-asserted-by":"crossref","unstructured":"Yan W, Peng LY, Ban CJ, et al. Incidence and clinical characteristics of pulmonary hypertension in subjects with idiopathic pulmonary fibrosis. Chin Med J (Engl) 2015;128:896-901.","DOI":"10.4103\/0366-6999.154284"},{"key":"12440","doi-asserted-by":"crossref","unstructured":"Cottin V, Le Pavec J, Pr\u00e9vot G, et al. Pulmonary hypertension in subjects with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010;35:105-11.","DOI":"10.1183\/09031936.00038709"},{"key":"12441","unstructured":"Hatano S, Strasser T, World Health Organization. Primary pulmonary hypertension: report on a WHO meeting, Geneva, 15-17 October 1973. World Health Organization; 1975."},{"key":"12442","doi-asserted-by":"crossref","unstructured":"Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019;53:1801913.","DOI":"10.1183\/13993003.01913-2018"},{"key":"12443","doi-asserted-by":"crossref","unstructured":"Haddad F, Zamanian R., Beraud A-S, et al. A novel non-invasive method of estimating pulmonary vascular resistance in subjects with pulmonary arterial hypertension. J Am Soc Echocardiogr 2009;22:523-9.","DOI":"10.1016\/j.echo.2009.01.021"},{"key":"12444","doi-asserted-by":"crossref","unstructured":"Currie PJ. Seward JB, Chan KL, et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 subjects. J Am Coll Cardiol 1985;6:750-6.","DOI":"10.1016\/S0735-1097(85)80477-0"},{"key":"12445","doi-asserted-by":"crossref","unstructured":"Amsallem M, Sternbach JM, Adigopula S, et al. Addressing the controversy of estimating pulmonary arterial pressure by echocardiography. J Am Soc Echocardiogr 2016;29:93-102.","DOI":"10.1016\/j.echo.2015.11.001"},{"key":"12446","unstructured":"Saleem SM. Modified Kuppuswamy scale for the year 2018. Papirex Indian J Res 2018;7:217-18."},{"key":"12447","doi-asserted-by":"crossref","unstructured":"Jones PW, Adamek L, Nadeau G et al. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. Eur Respir J 2013;42:647\u201354.","DOI":"10.1183\/09031936.00125612"},{"key":"12448","doi-asserted-by":"crossref","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111\u20137.","DOI":"10.1164\/ajrccm.166.1.at1102"},{"key":"12449","doi-asserted-by":"crossref","unstructured":"Guidelines for the measurement of respiratory function. Recommendations of the British Thoracic Society and the Association of Respiratory Technicians and Physiologists. Respir Med 1994;88:165\u201394.","DOI":"10.1016\/S0954-6111(05)80346-4"},{"key":"12450","doi-asserted-by":"crossref","unstructured":"Moore VC. Spirometry: step by step. Breathe 2012;8:232-40.","DOI":"10.1183\/20734735.0021711"},{"key":"12451","doi-asserted-by":"crossref","unstructured":"ATS\/ERS Task Force. Standardisation of Lung Fuction testing. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-58.","DOI":"10.1183\/09031936.05.00035205"},{"key":"12452","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD, 2018. Accessed: July 17, 2018. Available from: https:\/\/goldcopd.org\/gold-reports\/"},{"key":"12453","doi-asserted-by":"crossref","unstructured":"Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis- An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018;198:563\u201380.","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"12454","doi-asserted-by":"crossref","unstructured":"Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188:733\u201348.","DOI":"10.1164\/rccm.201308-1483ST"},{"key":"12455","doi-asserted-by":"crossref","unstructured":"Fischer A, Antoniou KM, Brown KK, et al. An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015;46:976-87.","DOI":"10.1183\/13993003.00150-2015"},{"key":"12456","doi-asserted-by":"crossref","unstructured":"Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685-713.","DOI":"10.1016\/j.echo.2010.05.010"},{"key":"12457","unstructured":"Mahan G, Dabestani A, Gardin J, et al. Estimation of pulmonary artery pressure by pulsed Doppler echocardiography. Circulation 1983;68:367."},{"key":"12458","unstructured":"Life in the Fastlane [Internet]. Pulmonary Hypertension Echocardiography. Accessed: 1st July, 2020. Available from: https:\/\/litfl.com\/pulmonary-hypertension-echocardiography\/"},{"key":"12459","doi-asserted-by":"crossref","unstructured":"Singh S, Collins BF, Sharma BB, et al. Interstitial lung disease in India. Results of a prospective registry. Am J Respir Crit Care Med 2017;195:801-13.","DOI":"10.1164\/rccm.201607-1484OC"},{"key":"12460","doi-asserted-by":"crossref","unstructured":"Dhooria S, Agarwal R, Sehgal IS, et al. Spectrum of interstitial lung diseases at a tertiary center in a developing country: A study of 803 subjects. PLoS One 2018;13:e0191938.","DOI":"10.1371\/journal.pone.0191938"},{"key":"12461","doi-asserted-by":"crossref","unstructured":"Akhter N, Rizvi NA. Interstitial lung diseases misdiagnosed as tuberculosis. Pak J Med Sci 2018;34:338-41.","DOI":"10.12669\/pjms.342.14407"},{"key":"12462","doi-asserted-by":"crossref","unstructured":"Kumar R, Gupta N, Goel N. Spectrum of interstitial lung disease at a tertiary care centre in India. Pneumonol Alergol Pol 2014;82:218-26.","DOI":"10.5603\/PiAP.2014.0029"},{"key":"12463","doi-asserted-by":"crossref","unstructured":"Sen T, Udwadia ZF. Retrospective study of interstitial lung disease in a tertiary care centre in India. Indian J Chest Dis Allied Sci 2010;52:207\u201311.","DOI":"10.5005\/ijcdas-52-4-207"},{"key":"12464","doi-asserted-by":"crossref","unstructured":"Karakatsani A, Papakosta D, Rapti A, et al. Epidemiology of interstitial lung diseases in Greece. Respir Med 2009;103:1122\u20139.","DOI":"10.1016\/j.rmed.2009.03.001"},{"key":"12465","doi-asserted-by":"crossref","unstructured":"Alhamad EH. Interstitial lung diseases in Saudi Arabia: A single-center study. Ann Thorac Med 2013;8:33\u20137.","DOI":"10.4103\/1817-1737.105717"},{"key":"12466","doi-asserted-by":"crossref","unstructured":"Musellim B, Okumus G, Uzaslan E, et al. Epidemiology and distribution of interstitial lung diseases in Turkey. Clin Respir J 2014;8:55\u201362.","DOI":"10.1111\/crj.12035"},{"key":"12467","doi-asserted-by":"crossref","unstructured":"Hyldgaard C, Hilberg O, Muller A, Bendstrup E. A cohort study of interstitial lung diseases in central Denmark. Respir Med 2014;108: 93\u20139.","DOI":"10.1016\/j.rmed.2013.09.002"}],"container-title":["Monaldi Archives for Chest Disease"],"original-title":[],"link":[{"URL":"https:\/\/www.monaldi-archives.org\/index.php\/macd\/article\/download\/2027\/1377","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.monaldi-archives.org\/index.php\/macd\/article\/download\/2027\/1377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T13:32:53Z","timestamp":1673962373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.monaldi-archives.org\/index.php\/macd\/article\/view\/2027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":41,"URL":"https:\/\/doi.org\/10.4081\/monaldi.2021.2027","relation":{},"ISSN":["2532-5264","1122-0643"],"issn-type":[{"value":"2532-5264","type":"electronic"},{"value":"1122-0643","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,6]]}}}